HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Failure of combination therapy with S-carbamyl-L-cysteine (SCC; NSC-102498) and L-asparaginase (NSC-109229) for L-asparaginase-resistant mouse lymphoma.

AuthorsM D Prager, L Rothberg
JournalCancer chemotherapy reports (Cancer Chemother Rep) Vol. 56 Issue 3 Pg. 339-41 (Jun 1972) ISSN: 0069-0112 [Print] United States
PMID19051493 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • S-carbamylcysteine
  • Asparaginase
  • Cysteine
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Asparaginase (administration & dosage)
  • Cell Line, Tumor
  • Cell Survival
  • Cysteine (administration & dosage, analogs & derivatives)
  • Drug Resistance, Neoplasm
  • Lymphoma (drug therapy)
  • Mice
  • Mice, Inbred C3H
  • Models, Biological
  • Models, Chemical
  • Neoplasm Transplantation
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: